Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine added to NSAIDs for OA knee pain
NCT01018680Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Nov 2009
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in osteoarthritis (OA) comparing Duloxetine + NSAIDs with Placebo + NSAIDs (2 arms). Primary endpoint: Change From Baseline in the Weekly Mean of the 24-Hour Average Pain Score at 8 Weeks. Started Nov 2009; status: completed.
02
Drugs
duloxetine
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01018680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01018680.